Glycotope   

Glycotope总部位于德国的柏林，拥有超过160名员工，Glycotope生物是拥有超过30年的生物制品GMP生产和分析制药行业的著名的伙伴，Glycotope结构进行药物开发中的广泛的客户的项目中，最引人注目的是生物仿制药的发展和改进的第二代疗法。

Glycotope是最大的糖基化蛋白生产商，是糖基化生物制药产品包括NBEs，biobetters和biosimilars开发和生产的龙头企业。在Glycotope大约有120人开发用于生物治疗的高产量的细胞生产线，生产工艺，和免疫学和生物化学的方法和生物测定方法，产品符合GMP标准。Glycotope产品线包括改进的抗体和治疗性蛋白质。

The Glycotope Group consists of Glycotope GmbH, based in Berlin, Germany and its 100% subsidiary, Glycotope Biotechnology GmbH, based in Heidelberg, Germany. With more than 160 employees, Glycotope represents one of the largest Biotech companies in Germany.

Together, the companies are active in the development of proprietary biopharmaceuticals based on Glycotope´s technologies for a new generation of protein therapeutics.

In our affiliate Glycotope Biotechnology, we perform a wide range of contract research and manufacturing services . While Glycotope Biotechnology, a former part of Orpegen Pharma GmbH, is for now more than 30 years a reknown partner of the pharmaceutical industry for GMP production and analytics of biologics, Glycotope Biotechnology is conducting customer projects in GMP-production and drug development.